Quality of life (QoL) measurement in economical analysis in cancer.
In health economy, the measure of quality of life (QoL) is essential in cost-utility analysis. The most common utility measure is the quality-adjusted-life year (QALY) combining the benefits of survival and QoL during the survival period. Health authorities have to take priority decisions. These should not be founded on differences between choices caused by method chosen. A study on 98 cancer patients (42 Hodgkin's disease, 56 colorectal cancer) was performed to clarify the consistency of three QoL-instruments [EuroQol questionnaire, simple QoL-scale, global QoL-measure (EORTC QLQ-C30)]. The three instruments were significantly correlated (p<0.001). Cost-utility analysis employing one of the three instruments are comparable.